AbFlow : End-to-end Paratope-Centric Antibody Design by Interaction Enhanced Flow Matching
- URL: http://arxiv.org/abs/2602.07084v1
- Date: Fri, 06 Feb 2026 07:47:59 GMT
- Title: AbFlow : End-to-end Paratope-Centric Antibody Design by Interaction Enhanced Flow Matching
- Authors: Wenda Wang, Yang Zhang, Zhewei Wei, Wenbing Huang,
- Abstract summary: AbFlow is a flow-matching framework that leverages optimal transport to design full-atom antibodies end-to-end.<n>It produces superior antigen-antibody complexes, especially at the contact interface, and markedly improves the binding affinity of generated antibodies.
- Score: 41.128304772190454
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Antigen-antibody binding is a critical process in the immune response. Although recent progress has advanced antibody design, current methods lack a generative framework for end-to-end modeling of full-atom antibody structures and struggle to fully exploit antigen-specific geometric information for optimizing local binding interfaces and global structures. To overcome these limitations, we introduce AbFlow, a flow-matching framework that leverages optimal transport to design full-atom antibodies end-to-end. AbFlow incorporates an extended velocity field network featuring an equivariant Surface Multi-channel Encoder, which uses surface-level antigen interaction data to refine the antibody structure, particularly the CDR-H3 region. Extensive experiments in paratoep-centric antibody design, multi-CDRs and full-atom antibody design, binding affinity optimization, and complex structure prediction show that AbFlow produces superior antigen-antibody complexes, especially at the contact interface, and markedly improves the binding affinity of generated antibodies.
Related papers
- Antibody Design and Optimization with Multi-scale Equivariant Graph Diffusion Models for Accurate Complex Antigen Binding [13.315597171727095]
We propose textbfAbMEGD, an end-to-end framework for antibody sequence and structure co-design.<n>AbMEGD combines atomic-level geometric features with residue-level embeddings, capturing local atomic details and global sequence-structure interactions.<n>Experiments using the SAbDab database demonstrate a 10.13% increase in amino acid recovery, 3.32% rise in improvement percentage, and a 0.062AA reduction in root mean square deviation.
arXiv Detail & Related papers (2025-06-26T02:45:38Z) - dyAb: Flow Matching for Flexible Antibody Design with AlphaFold-driven Pre-binding Antigen [52.809470467635194]
Development of therapeutic antibodies heavily relies on accurate predictions of how antigens will interact with antibodies.<n>Existing computational methods in antibody design often overlook crucial conformational changes that antigens undergo during the binding process.<n>We introduce dyAb, a flexible framework that incorporates AlphaFold2-driven predictions to model pre-binding antigen structures.
arXiv Detail & Related papers (2025-03-01T03:53:18Z) - Towards More Accurate Full-Atom Antibody Co-Design [44.06939390661133]
Co-design represents a critical frontier in drug development, where accurate prediction of structure of complementarity-determining regions is essential for targeting specific equivariants.<n>Despite recent advances in graph neural networks for antibody design, current approaches often fall short in capturing the intricate interactions that govern antibody-antigen recognition and binding specificity.<n>We present Igformer, a novel end-to-end framework that addresses these limitations through personalized antibody-antigen binding interfaces.
arXiv Detail & Related papers (2025-02-11T13:33:28Z) - Relation-Aware Equivariant Graph Networks for Epitope-Unknown Antibody Design and Specificity Optimization [61.06622479173572]
We propose a novel Relation-Aware Design (RAAD) framework, which models antigen-antibody interactions for co-designing sequences and structures of antigen-specific CDRs.<n> Furthermore, we propose a new evaluation metric to better measure antibody specificity and develop a contrasting specificity-enhancing constraint to optimize the specificity of antibodies.
arXiv Detail & Related papers (2024-12-14T03:00:44Z) - Efficient Antibody Structure Refinement Using Energy-Guided SE(3) Flow Matching [16.192361788505558]
FlowAB is a novel antibody structure refinement method based on energy-guided flow matching.
It achieves new state-of-the-art performance on the antibody structure prediction task when used in conjunction with an appropriate prior model.
arXiv Detail & Related papers (2024-10-22T04:13:55Z) - Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization [51.28231365213679]
We tackle antigen-specific antibody sequence-structure co-design as an optimization problem towards specific preferences.
We propose direct energy-based preference optimization to guide the generation of antibodies with both rational structures and considerable binding affinities to given antigens.
arXiv Detail & Related papers (2024-03-25T09:41:49Z) - A Hierarchical Training Paradigm for Antibody Structure-sequence
Co-design [54.30457372514873]
We propose a hierarchical training paradigm (HTP) for the antibody sequence-structure co-design.
HTP consists of four levels of training stages, each corresponding to a specific protein modality.
Empirical experiments show that HTP sets the new state-of-the-art performance in the co-design problem.
arXiv Detail & Related papers (2023-10-30T02:39:15Z) - xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence.
The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
arXiv Detail & Related papers (2022-11-30T09:26:08Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.